266 related articles for article (PubMed ID: 28854347)
1. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.
Wang HL; Kim CJ; Koo J; Zhou W; Choi EK; Arcega R; Chen ZE; Wang H; Zhang L; Lin F
Arch Pathol Lab Med; 2017 Sep; 141(9):1155-1180. PubMed ID: 28854347
[TBL] [Abstract][Full Text] [Related]
2. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
Chen ZE; Lin F
Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer in the elderly.
Wallach CB; Kurtz RC
Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
[TBL] [Abstract][Full Text] [Related]
4. An Update on the Role of Immunohistochemistry in the Evaluation of Pancreatic/Liver/Gastrointestinal Luminal Tract Disorders.
Huang J; Chen G; Li H
Arch Pathol Lab Med; 2023 Dec; 147(12):1374-1382. PubMed ID: 37134268
[TBL] [Abstract][Full Text] [Related]
5. Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas.
Geller SA; Dhall D; Alsabeh R
Arch Pathol Lab Med; 2008 Mar; 132(3):490-9. PubMed ID: 18318589
[TBL] [Abstract][Full Text] [Related]
6. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Jain R; Fischer S; Serra S; Chetty R
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):9-15. PubMed ID: 19956064
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
8. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
9. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract.
Itai S; Nishikata J; Yoneda T; Ohmori K; Yamabe H; Arii S; Tobe T; Kannagi R
Cancer; 1991 Mar; 67(6):1576-87. PubMed ID: 2001547
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonic diagnosis of neoplasms of liver, biliary tract and pancreas].
Kitamura T
Nihon Rinsho; 1982; 40(1):71-8. PubMed ID: 7087207
[No Abstract] [Full Text] [Related]
12. Advance of endoscopy.
Takemoto T; Okita K
Cancer Detect Prev; 1981; 4(1-4):385-99. PubMed ID: 7349801
[TBL] [Abstract][Full Text] [Related]
13. [The optimization of the detection of tumors of the organs of the hepatobiliopancreatic area by a combination of the ultrasonic study method and of the determination of tumor markers in the blood serum].
Mit'kov VV; Briukhovetskiĭ IuA
Ter Arkh; 1992; 64(4):86-9. PubMed ID: 1440318
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic usefulness of Ca 19-9 antigen in cancer of the pancreas and neoplasms of the pancreato-biliary intersection].
Robles-Diáz G; Aceves G; Galván E
Gac Med Mex; 1990; 126(2):78-82; discussion 82-3. PubMed ID: 2387490
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
Okuda K; Tsuchiya Y; Saisho H
Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
[No Abstract] [Full Text] [Related]
16. [Liver, pancreas, biliary tract cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1295-6. PubMed ID: 24312978
[No Abstract] [Full Text] [Related]
17. [Ultrasonic percutaneous imaging of neoplasms of liver, biliary tract and pancreas].
Tsuchiya Y; Nakano T; Tsunetomi S; Shinagawa T; Ukazi H; Unozawa T; Iino Y; Watanabe J; Morita M; Kimura K; Saisyo H; Ohto M; Ebara M; Karasawa E; Saotome N
Nihon Rinsho; 1982; 40(1):102-8. PubMed ID: 6283196
[No Abstract] [Full Text] [Related]
18. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
19. [Liver, Pancreas, Biliary Tract Cancer Current Issues of Surgical Margin, R0 and R1, in Surgical Resection for Hepatobiliary Pancreatic Cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1415-1416. PubMed ID: 30382035
[No Abstract] [Full Text] [Related]
20. Utility of immunohistochemistry in the pancreatobiliary tract.
Lin F; Chen ZE; Wang HL
Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
